"Pharma start-up" is a broad definition which might not only be drug development and there might already be work done on their product before they look for fund

"Pharma start-up" is a broad definition which might not only be drug development and there might already be work done on their product before they look for funding A company that is spun out from a PhD project in a research group, that has done a lot of the groundwork on grants will need less funding Same goes for a start-up that for instance make non-invasive assays for diagnosis, since the documentation requirements are lower for such products Producing something that has to be injected into humans is an entirely different league, since the amount of documentation required for such products is staggering The cost for marketing will vary significantly depending on your definition of the word, and I suspect that it might be misconstrued as only being "commercials and paid holidays for doctors"